130 results on '"Ellert, Julia"'
Search Results
2. Early vascular healing after implantation of the polymer-free biolimus-eluting stent or the ultrathin strut biodegradable polymer sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction
3. TCT-418 Impact of Diabetes on Clinical Outcomes After Percutaneous Coronary Intervention: 5-Year Results of the SORTOUT IX Trial Comparing the Polymer-Free Biolimus A9-Coated Stent to the Ultra-Thin Strut Biodegradable Polymer Sirolimus-Eluting Stent
4. TCT-708 5-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stent With Biodegradable Polymer: From the SORT OUT VII Trial
5. TCT-669 Impact of Acute Coronary Syndromes on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With the Biolimus-Coated BioFreedom Stent or Biodegradable Polymer Sirolimus-Eluting Orsiro Stent: From the SORT OUT IX Trial
6. Culprit lesion morphology in patients with ST-segment elevation myocardial infarction assessed by optical coherence tomography
7. Clinical outcomes three-year after revascularization with biodegradable polymer stents: ultrathin-strut sirolimus-eluting stent versus biolimus-eluting stent: from the Scandinavian organization for randomized trials with clinical outcome VII trial
8. Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial
9. Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
10. Optical Coherence Tomography- Versus Angiography-Guided Magnesium Bioresorbable Scaffold Implantation in NSTEMI Patients
11. Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
12. Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared With the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial
13. Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent.
14. Grado de perfusión miocárdica, índices de rescate miocárdico y mortalidad a largo plazo en pacientes con infarto agudo de miocardio y restablecimiento completo del flujo sanguíneo epicárdico tras intervención coronaria percutánea primaria
15. Myocardial Perfusion Grade, Myocardial Salvage Indices and Long-Term Mortality in Patients With Acute Myocardial Infarction and Full Restoration of Epicardial Blood Flow After Primary Percutaneous Coronary Intervention
16. TCT-151 Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared With the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial
17. TCT-278 Five-Year Outcomes After Revascularization With the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Orsiro Stent or the Biodegradable Polymer Biolimus-Eluting Nobori Stent in Patients With and Without Acute Coronary Syndromes: From the SORT OUT VII Trial
18. Influence of Plaque Characteristics on Early Vascular Healing in Patients With ST-Elevation Myocardial Infarction
19. Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial
20. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study
21. Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period
22. Assessment of Platelet Function With Light Transmission Aggregometry and Multiple Electrode Platelet Aggregometry Before and After Clopidogrel Treatment: 2801-7
23. Late Coronary Healing Assessed With Optical Coherence Tomography After Magnesium Bioresorbable Scaffold Implantation
24. Outcomes After Revascularization With a Polymer-Free Biolimus-Eluting BioFreedom Stent or a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Orsiro Stent in Patients With and Without Acute Coronary Syndromes: From the SORT OUT IX Trial
25. Very Late Stent Thrombosis after Revascularization with Biodegradable Polymer Drug-Eluting Stents. From the SORT OUT VII Trial
26. Early Vascular Healing after Implantation of a Biolimus-Coated BioFreedom stent or a Sirolimus Eluting Orsiro stent in Patients with ST-segment Elevation Myocardial Infarction
27. Culprit Lesion Types and Vascular Healing in Patients with ST-segment Elevation Myocardial Infarction after Primary Percutaneous Intervention
28. Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII trial
29. Early Changes in Malapposition Assessed with Optical Coherence Tomography after Biolimus-coated BioFreedom Stent or Sirolimus Eluting Orsiro Stent in Patients with ST-segment Elevation Myocardial Infarction
30. TCT-290 Outcomes After Revascularization With a Polymer-Free Biolimus-Eluting BioFreedom Stent or a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Orsiro Stent in Patients With and Without Acute Coronary Syndromes: From the SORT OUT IX Trial
31. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial
32. TCT-192 Late Coronary Healing Assessed With Optical Coherence Tomography After Magnesium Bioresorbable Scaffold Implantation
33. Impact of diabetes on clinical outcomes after revascularization with sirolimus‐eluting and biolimus‐eluting stents with biodegradable polymer from the SORT OUT VII trial
34. TCT-90 Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII trial.
35. TCT-347 Culprit Lesion Types and Vascular Healing in Patients with ST-segment Elevation Myocardial Infarction after Primary Percutaneous Intervention
36. TCT-737 Very Late Stent Thrombosis after Revascularization with Biodegradable Polymer Drug-Eluting Stents. From the SORT OUT VII Trial
37. Percutaneous biventricular cardiac assist device in cardiogenic shock and refractory cardiac arrest
38. Association of intraoperative transit time flow after grafting and invasive coronary flow and pressure measurements before coronary artery bypass surgery
39. Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer. From the SORT OUT VII Trial
40. TCT-758 Influence of Gender Differences on Invasive Coronary Microvascular and Flow Measurements in Patients with Stable Angina
41. Early restenose in a polymer-free Biolimus A9-coated stent (BioFreedom): A case report based on optical coherence tomography
42. Impact of diabetes on clinical outcomes after revascularization with sirolimus‐eluting and biolimus‐eluting stents with biodegradable polymer from the SORT OUT VII trial.
43. TCT-245 Association of intraoperative transit time flow after grafting and invasive coronary flow and pressure measurements before coronary artery bypass surgery.
44. TCT-348 Early Changes in Malapposition Assessed with Optical Coherence Tomography after Biolimus-coated BioFreedom Stent or Sirolimus Eluting Orsiro Stent in Patients with ST-segment Elevation Myocardial Infarction
45. TCT-757 Culprit Lesion Composition in Patients with ST-segment Elevation Myocardial Infarction assessed by Optical Coherence Tomography
46. Mutation des Chymase Gens im aktiven Zentrum und ihre Beziehung zu dermatologischen Erkrankungen
47. Mutation des Chymase Gens im aktiven Zentrum und ihre Beziehung zu dermatologischen Erkrankungen
48. Mutation des Chymase Gens im aktiven Zentrum und ihre Beziehung zu dermatologischen Erkrankungen
49. FIVE-YEAR PROGNOSTIC VALUE OF NO-REFLOW PHENOMENON AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
50. Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.